Peer reviews....would this help with subsiding some of the ghost writing documentation we recently saw with Merck by using publications outside the "official" reporting process? BD
Claims that the pharmaceutical company Merck hired ghostwriters for Vioxx articles has put heat on a U.S. proposal to loosen drug promotion rules.
The FDA reportedly has taken a proposal into consideration that would allow drug companies to use peer-reviewed articles for the promotion of off-label drugs the administration has yet to approve.
Public Citizen, New York's state health commissioner and the Blue Cross Blue Shield Association have all said they oppose the FDA plan, the Times reported.
0 comments :
Post a Comment